|
2025 Journal Article A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factorsBhasker, Vikas, Brown, Catherine, Fong, Jessica R., Clark, Paul J., Hartel, Gunter, Skoien, Richard, O'Beirne, James, Wheeler, Kai, Keating, Shelley E., Powell, Elizabeth E. and Valery, Patricia C. (2025). A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factors. The Lancet Regional Health - Western Pacific, 61 101641. doi: 10.1016/j.lanwpc.2025.101641 |
|
2025 Conference Publication First nations Australians with cirrhosis have higher and premature mortality and multiple cofactorsBrown, Catherine, Bhasker, Vikas, Fong, Jessica, Clark, Paul, Hartel, Gunter, Skoien, Richard, O’Beirne, James, Powell, Elizabeth E. and Valery, Patricia (2025). First nations Australians with cirrhosis have higher and premature mortality and multiple cofactors. EASL Congress 2025, Amsterdam, Netherlands, 7-10 May 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(25)01768-4 |
|
2025 Journal Article Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver diseaseGracen, Lucy, Hartel, Gunter, Irvine, Katharine M., Aikebuse, Melanie, Valery, Patricia C. and Powell, Elizabeth E. (2025). Factors to consider in the selection of non-invasive fibrosis tests for metabolic dysfunction-associated steatotic liver disease. Clinical Gastroenterology and Hepatology, 23 (5), 874-876. doi: 10.1016/j.cgh.2024.09.014 |
|
2025 Journal Article Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial)Allen, Michelle J., Tulleners, Ruth, Brain, David, O’Beirne, James, Powell, Elizabeth E., Barnett, Adrian, Valery, Patricia C., Kularatna, Sanjeewa and Hickman, Ingrid J. (2025). Implementation of a nurse-delivered, community-based liver screening and assessment program for people with metabolic dysfunction-associated steatotic liver disease (LOCATE-NAFLD trial). BMC Health Services Research, 25 (1) 421, 1-13. doi: 10.1186/s12913-025-12580-5 |
|
2025 Journal Article A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final surveySenanayake, Sameera, Barnett, Adrian, Brain, David, Allen, Michelle, Powell, Elizabeth E., O’Beirne, James, Valery, Patricia, Hickman, Ingrid J. and Kularatna, Sanjeewa (2025). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia: designing the choice sets for the final survey. F1000Research, 14 96, 1-17. doi: 10.12688/f1000research.157017.1 |
|
2025 Journal Article High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLDPowell, Elizabeth E., Hartel, Gunter, Irvine, Katharine M., O’Beirne, James, Bhasker, Vikas and Valery, Patricia C. (2025). High FIB4 is associated with increased risk of cirrhosis decompensation and liver-related mortality in at-risk patients with MASLD. Gastro Hep Advances, 4 (4) 100607, 1-3. doi: 10.1016/j.gastha.2024.100607 |
|
2024 Journal Article Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLDTulleners, Ruth, Barnett, Adrian, O'Beirne, James, Powell, Elizabeth, Hickman, Ingrid J., Valery, Patricia C., Kularatna, Sanjeewa, Stuart, Katherine, McIvor, Carolyn, Witness, Elen, Aikebuse, Melanie and Brain, David (2024). Parallel randomised trial testing community fibrosis assessment for suspected non-alcoholic fatty liver disease: outcomes from LOCATE-NAFLD. BMJ Open Gastroenterology, 11 (1) e001418, e001418. doi: 10.1136/bmjgast-2024-001418 |
|
2024 Journal Article A new treatment and updated clinical practice guidelines for MASLDPowell, Elizabeth E. (2024). A new treatment and updated clinical practice guidelines for MASLD. Nature Reviews Gastroenterology and Hepatology, 22 (2), 88-89. doi: 10.1038/s41575-024-01014-y |
|
2024 Conference Publication CAUSE-SPECIFIC MORTALITY AMONG AUSTRALIANS WITH CIRRHOSIS DIFFERS BY CIRRHOSIS ETIOLOGY AND DECOMPENSATION STATUSBhasker, Vikas, Clark, Paul, Hartel, Gunter, Skoien, Richard, Powell, Elizabeth and Valery, Patricia (2024). CAUSE-SPECIFIC MORTALITY AMONG AUSTRALIANS WITH CIRRHOSIS DIFFERS BY CIRRHOSIS ETIOLOGY AND DECOMPENSATION STATUS. The Liver Meeting, San Diego Ca, Nov 15-19, 2024. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. |
|
2024 Conference Publication A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerationsAikebuse, Melanie, Gracen, Lucy, Sarraf, Babak, Mcphail, Steven, Russell, Anthony, O'Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). A community-based MASLD care pathway for people with type 2 diabetes: barriers and considerations. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2024, Adelaide, SA Australia, 14-16 September 2024. Richmond, VIC Australia: John Wiley & Sons. |
|
2024 Journal Article An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerationsGracen, Lucy, Aikebuse, Melanie, Sarraf, Babak, McPhail, Steven, Russell, Anthony, O’Beirne, James, Irvine, Katharine, Williams, Suzanne, Valery, Patricia and Powell, Elizabeth (2024). An Australian community-based metabolic dysfunction-associated steatotic liver disease care pathway for people with type 2 diabetes: barriers and considerations. Patient Preference and Adherence, Volume 18, 1845-1855. doi: 10.2147/ppa.s468705 |
|
2024 Journal Article Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancerPowell, Elizabeth E., Roche, Shruti, Sarraf, Babak, Hartel, Gunter, Skoien, Richard, Leggett, Barbara, O'Beirne, James and Valery, Patricia C. (2024). Australians with metabolic dysfunction‐associated steatotic liver disease have a twofold increase in the incidence of cancer. JGH Open, 8 (7) e70000, e70000. doi: 10.1002/jgh3.70000 |
|
2024 Journal Article Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage studySarraf, B., Skoien, R., Hartel, G., O'Beirne, J., Clark, P. J., Collins, L., Leggett, B., Powell, E. E. and Valery, P. C. (2024). Rising hospital admissions for alcohol-related cirrhosis and the impact of sex and comorbidity – a data linkage study. Public Health, 232, 178-187. doi: 10.1016/j.puhe.2024.04.030 |
|
2024 Conference Publication qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopyKleiner, David E., Clouston, Andrew D., Goodman, Zachary, Guy, Cynthia D., Brunt, Elizabeth M., Lackner, Carolin, Tiniakos, Dina G., Wee, Aileen, Yeh, Matthew, Leow, Wei Qiang, Chng, Elaine, Ren, Yayun, Goh, George Boon Bee, Powell, Elizabeth E., Rinella, Mary E., Sanyal, Arun J, Neuschwander-Tetri, Brent A., Younossi, Zobair, Charlton, Michael, Ratziu, Vlad, Harrison, Stephen A., Tai, Dean and Anstee, Quentin M. (2024). qBallooning: AI-based ballooned hepatocyte detection and quantification by second harmonic generation/two photon excitation microscopy. EASL Congress 2024, Milan, Italy, 5-8 June 2024. Amsterdam, Netherlands: Elsevier. doi: 10.1016/s0168-8278(24)01444-2 |
|
2024 Journal Article High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in AustraliaValery, Patricia C., Roche, Shruti, Brown, Catherine, O’Beirne, James, Hartel, Gunter, Leggett, Barbara, Skoien, Richard and Powell, Elizabeth E. (2024). High prevalence of diabetes among young First Nations Peoples with metabolic dysfunction-associated steatotic liver disease: a population-based study in Australia. International Journal for Equity in Health, 23 (1) 84, 1-11. doi: 10.1186/s12939-024-02153-z |
|
2024 Journal Article A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, AustraliaSenanayake, S., Barnett, A., Brain, D., Allen, M., Powell, E.E., O'Beirne, J., Valery, P., Hickman, I.J. and Kularatna, S. (2024). A discrete choice experiment to elicit preferences for a chronic disease screening programme in Queensland, Australia. Public Health, 228, 105-111. doi: 10.1016/j.puhe.2024.01.007 |
|
2024 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Arab, Juan Pablo, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Narro, Graciela E. Castro, Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2024). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Annals of Hepatology, 29 (1) 101133, 101133. doi: 10.1016/j.aohep.2023.101133 |
|
2023 Journal Article A multisociety Delphi consensus statement on new fatty liver disease nomenclatureRinella, Mary E., Lazarus, Jeffrey V., Ratziu, Vlad, Francque, Sven M., Sanyal, Arun J., Kanwal, Fasiha, Romero, Diana, Abdelmalek, Manal F., Anstee, Quentin M., Pablo Arab, Juan, Arrese, Marco, Bataller, Ramon, Beuers, Ulrich, Boursier, Jerome, Bugianesi, Elisabetta, Byrne, Christopher D., Castro Narro, Graciela E., Chowdhury, Abhijit, Cortez-Pinto, Helena, Cryer, Donna R., Cusi, Kenneth, El-Kassas, Mohamed, Klein, Samuel, Eskridge, Wayne, Fan, Jiangao, Gawrieh, Samer, Guy, Cynthia D., Harrison, Stephen A., Kim, Seung Up ... Newsome, Philip N. (2023). A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 78 (6), 1966-1986. doi: 10.1097/HEP.0000000000000520 |
|
2023 Journal Article Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonistsGracen, Lucy, Muthukumara, Withma, Aikebuse, Melanie, Russell, Anthony, O'Beirne, James, Irvine, Katharine M., Williams, Suzanne, Puri, Gaurav, Valery, Patricia C., Hayward, Kelly L. and Powell, Elizabeth E. (2023). Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists. Annals of Hepatology, 28 (6) 101142, 101142. doi: 10.1016/j.aohep.2023.101142 |
|
2023 Journal Article Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeuticsHuang, Gary, Wallace, Daniel F., Powell, Elizabeth E., Rahman, Tony, Clark, Paul J. and Subramaniam, V. Nathan (2023). Gene variants implicated in steatotic liver disease: opportunities for diagnostics and therapeutics. Biomedicines, 11 (10) 2809, 1-15. doi: 10.3390/biomedicines11102809 |
